N-Acetyl Selank Amidate

Acetylated, amidated Selank analog, 10mg vial

$85.00

Format Lyophilized powder, vial

Purity ≥99% (HPLC)

CAS 2920938-92-5

Documentation COA by request

This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.

FAQ

Common questions

How does this differ from standard Selank?+

Same tuftsin-derived core sequence, with added N-terminal acetylation and C-terminal amidation.

Is this related to N-Acetyl Semax Amidate?+

Both use the same acetylation/amidation modification pattern, applied to different parent peptides (Selank vs. Semax).

What CAS number identifies this analog?+

2920938-92-5.

About

About N-Acetyl Selank Amidate

N-Acetyl Selank Amidate is a modified analog of Selank carrying an N-terminal acetyl group and C-terminal amidation, the same class of terminal modification used across this site's Semax-analog listings. Synthesized to ≥99% purity (HPLC); certificate of analysis available per batch. For laboratory research use only.

You may also want

#neuropeptides Dihexa Sold out

Neuropeptides

Angiotensin IV-derived c-Met pathway agonist, 10mg vial

Lyophilized powder, vial · 2 sizes

#neuropeptides Dihexa (Capsules) Sold out

Neuropeptides

Dihexa, 8mg x 30 capsules

Capsules, bottle · 1 size

#neuropeptides DSIP Sold out

Neuropeptides

Nonapeptide first isolated from cerebral venous blood, 5mg vial

Lyophilized powder, vial · 2 sizes